PROCEPT BioRobotics

PROCEPT BioRobotics

Health Care Equipment & Supplies
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, which are image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.

$1B

Market Cap • 9/29/2026

2021

(5 years)

Founded

2021

(5 years ago)

IPO

NASDAQ

Listing Exchange

Flag of United States

United States

Country

Valuation

P/B

3,1

P/S

3,1

P/EBITDA

—

P/OCF

—

P/FCF

—

P/E

—

BVPS

6

EPS

—

Market Cap

Market Cap

1B

EV

893,1M

EV/Revenue

2,6

EV/EBITDA

-8,3

EV/EBIT

-7,8

Payout

Dividend Per Share

0

Dividend Yield

0%

Buyback Yield

-1%

Total Yield

-1%

Payout

0%

Retained Earnings

-700,1M

Profitability

Gross Margin

64,2%

EBITDA Margin

—

EBIT Margin

—

Net Margin

—

D&A/EBITDA

0%

R&D/Revenue

23,4%

Capex/Revenue

3,1%

Capex/D&A

150,1%

Capex/OCF

-14,2%

SBC/OCF

—

% PPE

10,1%

% Goodwill

0%

ROE

—

ROIC

—

Growth

CAGR Revenue 5Y

74,3%

CAGR Op. Income 5Y

18,6%

CAGR Net Income 5Y

14,9%

CAGR EPS 5Y

-29,7%

CAGR OCF 5Y

7,2%

Leverage

N.D./EBITDA

1,4

Debt/Equity

0%

Current Ratio

6,5

Quick Ratio

5,2

Interest Coverage

—

Premium

Unlock 100% of the data and have immediate access on more than 6.000 companies with updated information!
  • Unrestricted access
  • Unlimited data history
  • Analysis videos
  • Quarterly highlights
  • Customizable financials table
  • Ranking
  • Discussions

...and much more!

Get Premium